URGN - UroGen Pharma Ltd Company Long-Term Liabilities

Public company logo of UroGen Pharma Ltd (URGN)

UroGen Pharma Ltd. (URGN) is developing a targeted delivery system for urinary system tumors via RTGel technology, creating a barrier to switching to alternative drugs. The delivery of these agents to medical centers relies on strict pharmaceutical control. The market's valuation trend for the asset captured the 0.00 metric. Future prospects depend on compliance with waste disposal standards and the office's basic environmental policy.

urogen.com (URGN) Company Long-Term Debt: for the period 07/04/2022 - 10/31/2026

UroGen (URGN) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price urogen.com|URGN - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation UroGen Pharma|URGN - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share UroGen Pharma|URGN - Company Book Value|Market Value to Book Value urogen.com|URGN - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio UroGen Pharma Ltd.|URGN - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio UroGen Pharma Corp|URGN - Company Total Debt|Debts to Book Capitalization UroGen Pharma|URGN - Company Long-Term Debt|Company Short-Term Loans and Borrowings UroGen Pharma|Immediate Liquidity urogen.com
- earnings and market multiples details:
URGN - Net Income
Fundamental company valuation:URGN (urogen.com)
Brand item of UroGen Pharma Ltd.

Reducing the debt load is critical for improving fundamental multiples and the capitalization of UroGen Pharma Ltd. (URGN) during the drug commercialization period. By analyzing the organization's long-term financial debt, an investor assesses the volume of multi-year obligations and the risk of covenant breaches, which is particularly relevant for UroGen Pharma Ltd. (URGN) given volatile cash flows and the dependence of revenue on the pace of insurance coverage for the therapy.

Competitors of UroGen Pharma Ltd. (URGN)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt Bicara Therapeutics Inc.|PSNL: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities ERAS (Erasca)|DCTH (Delcath Systems Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts YMAB (YmAbs)|AURA - Company Long-Term Liabilities|CADL: Company Long-Term Liabilities|ARAY - Company Long-Term Debts|sellaslifesciences.com (SLS) - Company Long-Term Debt|Actuate Therapeutics Inc. - Company Long-Term Loans and Borrowings|CTOR (Citius Oncology, Inc) - Company Long-Term Debts|Long-Term Debt TuHURA HURA|Company Long-Term Liabilities TARA (Protara Therapeutics)|Company Long-Term Debts fatetherapeutics.com (FATE)|Company Long-Term Debt Aadi Bioscience WHWK|Company Long-Term Loans and Borrowings TCRX|CSBR - Company Long-Term Debt|Long-Term Debt XBiotech Inc.|CVM: Company Long-Term Debts|Long-Term Indebtedness ostherapies.com OSTX|RADX (Radiopharm Theranostics Limited) - Company Long-Term Debts|Long-Term Debt Artiva ARTV|Company Long-Term Debt Adlai Nortye Ltd. (ANL)|Veru Corporation - Company Long-Term Indebtedness|Tempest Therapeutics - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings XLO|RENB - Company Long-Term Debt|Long-Term Liabilities MURA|KAPA: Company Long-Term Debts|OnKure Therapeutics - Company Long-Term Loans and Borrowings|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|Company Long-Term Debts Curis Corp|Company Long-Term Debt Apollomics, Inc. (APLM)|THAR (Tharimmune Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Advanced Biomed ADVB|GNPX - Company Long-Term Liabilities|Calidi Bio - Company Long-Term Debts|SBFM - Company Long-Term Debts|XBIO (xeneticbio.com) - Company Long-Term Liabilities|Salarius Pharmaceuticals Inc - Company Long-Term Loans and Borrowings|Company Long-Term Debt Purple Biotech Corp|Company Long-Term Debt AONC|Company Long-Term Liabilities BGNE (BeiGene, Ltd.)|Amount of Long-Term Liabilities CKPT|Company Long-Term Debts ELEV (Elevation Oncology, Inc.)|ICAD: Company Long-Term Indebtedness|IKNA: Company Long-Term Liabilities|Long-Term Debt Volume Notable Labs Corp NTBL|VIRX (viracta.com) - Company Long-Term Liabilities|morphosys.com (MOR) - Company Long-Term Debts|Company Long-Term Debt NAYA Biosciences Inc.|AAPGV: Company Long-Term Loans and Borrowings